Classification of Hodgkin's Disease Biopsies by a Panel of Four Histopathologists Report of 1,140 Patients from the German National Trial

References

• Colby T. V., Hoppe R. T., Warnke R. A. Hodgkin's disease: a clinico-pathologic study of 659 cases. Cancer 1982; 49: 1848–58
   PubMed Web of Science ®Google Scholar
• Russell K. J., Hoppe R. T., Colby T. V., et al. Lymphocyte predominant Hodgkin's disease: clinical presentation and results of treatment. Radiother. Oncol. 1984; 1: 197–205
   PubMedGoogle Scholar
• Bennett M. H., MacLennan K. A., Easterling M. J., . Analysis of histological subtypes of Hodgkin's disease in relation to prognosis and survival. In: The. Cytobiology in Leukaemias and Lymphomas, D. Quaglino, F. G. J. Hayhoe, et al. Serono Publications, Raven Press, New York 1985; 15–32, 20
   Google Scholar
• Bennett M. H., MacLennan K. A., Vaughan Hudson B., et al. The clinical and prognostic relevance of histopathologic classification in Hodgkin's disease. Progress in Surg. Pathol. 1991; 10: 127–51
   Google Scholar
• MacLennan K. A., Bennett M. H., Tu A., . Prognostic significance in cytologic subdivision in nodular sclerosing Hodgkin's disease: An analysis of 1156 patients. In:. Malignant lymphomas and Hodgkin's Disease: experimental and therapeutic advances, F. Cavalli, G. Bonnadonna, M. Rosenczweig, et al. Nijhoff, Boston 1985; 187–-200
   Google Scholar
• MacLennan M. A., Bennett M. H., Tu A., et al. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease. Cancer 1989; 64: 1686–93
   PubMed Web of Science ®Google Scholar
• Coppleson L. W., Factor R. M., Strum S. B., et al. Observer disagreement in classification and histology of Hodgkin's disease. J. Natl. Cancer fnst. 1970; 45: 731–740
   PubMed Web of Science ®Google Scholar
• Kim H., Zeiman R. J., Fox M. A., et al. Pathology panel for lymphoma clinical studies. A comprehensive analysis of cases accumulated since its inception. J. Natl. Cancer Inst. 1982; 68: 43–67
   PubMed Web of Science ®Google Scholar
• Möller P. Peanut lectin: A useful tool for detection of Hodgkin's cells in paraffin sections. Virchows Arch. A Pathol. Anal. 1982; 396: 313–17
   Google Scholar
• Ferry J. A., Linggood R. M., Willett C. G., et al. The prognostic importance of sub-classification of Hodgkin's disease, nodular sclerosis type. Lab. Invest. 1989; 60(162)28A
   Google Scholar
• Georgii A., Fischer R., Hübner K., et al. Histopatholo-gische Klassifikation von Hodgkin-Lymphomen. Bericht der Referenzpathologie der Deutschen Hodgkin-Studie. Pathologe 1990; 11: 322–26
   PubMedGoogle Scholar
• Poppema S., Kaiserling E., Lennert K. Nodular paragranuloma and progressively transformed germinal centres: Ultrastructural and immunohistologic findings. Virchows Arch. B Cell Path. 1979; 31: 211–25
   Google Scholar
• Stein H., Gerdes J., Schwab U., et al. Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small cell population. Int. J. Cancer 1982a; 3: 445–59
   Web of Science ®Google Scholar
• Stein H., Uchanska-Ziegler B., Gerdes J., et al. Hodgkin and Sternberg-Reed cells contain antigens specific to late cells in granulopoiesis. Int. J. Cancer 1982b; 28: 283–90
   Web of Science ®Google Scholar
• Stein H., Hansmann M.-L., Lennert K., et al. Reed-Sternberg and Hodgkin cells in lymphocyte predominant Hodgkin's disease of nodular subtype contain J-chain. Am. J. Clin. Pathol. 1986; 86: 292–297
   PubMed Web of Science ®Google Scholar
• Warnke R. A., Gatter K. D., Falini B., et al. Diagnosis of human lymphoma with monoclonal antileukocyte common antibodies. AT. Engl. J. Med. 1983; 309: 1275–81
   PubMed Web of Science ®Google Scholar
• Warnke R. A., Rouse V. Limitations encountered in the application of tissue section immunodiagnosis to the study of lymphomas and related disorders. Hum. Pathol. 1985; 16: 326–31
   PubMed Web of Science ®Google Scholar
• Pinkus G. S., Said J. W. Hodgkin's disease, lymphocyte predominant type nodular–a distinct entity? Unique staining profile of L & H variants of Reed-Sternberg cells to leukocyte common antigen, granulocyte specific antigen and B-cell specific antigen. Am. J. Pathol. 1985; 118: 1–6
   PubMed Web of Science ®Google Scholar
• Kadin M. E., Sako D., Berliner N., et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood 1986; 68: 1042–49
   PubMed Web of Science ®Google Scholar
• Agnarsson B. A., Kadin M. E. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am. J. Surg. Pathol. 1988; 12(4)264–-274
   PubMed Web of Science ®Google Scholar
• Hansmann M.-L., Fellbaum C., Hui P. K., et al. Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am. J. Clin. Pathol. 1990; 93: 219–226
   PubMed Web of Science ®Google Scholar
• Dorfman R. F., Gatter K. C., Pulford K. A. F. An evaluation of the utility of anti-granulocytic and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease. Am. J. Pathol. 1986; 123: 508–519
   PubMed Web of Science ®Google Scholar
• Hall P. A., D'Ardenne A. J. Value of CD 15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. J. Clin. Pathol. 1987; 40: 1298–1304
   PubMed Web of Science ®Google Scholar
• Hall P. A., D'Ardenne A. J., Stansfeld A. G. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki 1) lymphoma. Histopathology 1988; 13: 161–69
   PubMed Web of Science ®Google Scholar
• Chittal S. M., Caveriviere R., Schwarting R., Gerdes J., et al. Monoclonal antibodies in the diagnosis of Hodgkin's disease: the search for a rational panel. Am. J. Surg. Pathol. 1988; 12: 9–21
   PubMed Web of Science ®Google Scholar
• Pinkus G. S., Said J. W. Hodgkin's disease, lymphocyte predominance type, nodular–further evidence for a B cell derivation. Am. J. Pathol. 1988; 133: 211–17
   PubMed Web of Science ®Google Scholar
• Banks P. M., Lust J. A., Thibodeau S. N. Nodular lymphocyte predominance Hodgkin's disease (NLPHD) and its transition to large cell lymphoma (LCL): Immunophenotypic and geneteic probe analysis. Lab. Invest. 1989; 60: 5A, (28)
   Web of Science ®Google Scholar
• Werner M., Georgii A., Bernhards J., et al. Characterization of giant cells in Hodgkin's lymphomas by immunohistochemistry applied to randomly collected diagnostic biopsies from the German Hodgkin Trial. Hematol Oncol. 1990; 8: 241–50
   PubMed Web of Science ®Google Scholar
• Regula D. P., Jr., Hoppe R. T., Weiss L. M. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N. Engl J. Med. 1988; 318: 214–19
   PubMed Web of Science ®Google Scholar
• Timens W., Visser L., Poppema S. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal centre lymphoma. Lab. Invest. 1986; 54: 457–61
   PubMed Web of Science ®Google Scholar
• Hansmann M.-L., Stein H., Dallenbach F., et al. Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type. Am. J. Pathol. 1991; 138: 29–36
   PubMed Web of Science ®Google Scholar
• Alavaiko M. J., Hansmann M.-L., Nebendahl C., et al. Follicular dendritic cells in Hodgkin's disease. Am. J. Clin. Pathol. 1991; 95: 194–200
   PubMed Web of Science ®Google Scholar
• Hansmann M.-L., Fellbaum C., Bohm A. Large cell anaplastic lymphoma: evaluation of immunophenotype on paraffin and frozen sections in comparison with ultrastructural features. Virchom Arch. A Pathoi. Anat. 1991; 418: 427–33
   Web of Science ®Google Scholar
• Wijlhuizen T. J., Vrints L. W., Jairam R., et al. Grades of nodular sclerosis (NS I-NS II) in Hodgkin's disease: Are they of independent prognostic value?. Cancer 1989; 63: 1150–53
   PubMed Web of Science ®Google Scholar
• Masih A. S., Weisenburger D. D., Vose J. M., et al. Histologic grade in nodular sclerosing Hodgkin's disease does not predict outcome. Lab. Invest. 1989; 60: 59A, (347)
   Web of Science ®Google Scholar
• Nanba K., Yamamoto H., Kamada N., et al. Agreement rates and American-Japanese Pathologists' comparability of a modified Working Formulation for non-Hodgkin's lymphomas. An analysis of the cases collected for the fifth International Workshop on chromosomes in leukemia-lymphoma. Cancer 1987; 59: 1463–69
   PubMed Web of Science ®Google Scholar